Published in Blood Weekly, September 14th, 2006
According to S. Sasazuki and colleagues at the Japan National Cancer Center in Tokyo, "Possible effect modification by CagA status, and serum pepsinogen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.